
Imed Pharmaceuticals (India) Private Limited
About Imed Pharmaceuticals (India) Private Limited
Data last updated:
Imed Pharmaceuticals (India) Private Limited is a private limited company based in Hubli, Karnataka, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 15 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24200KA2008PTC047159. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹89.92 Lakh. It is led by directors Narasappa Swamy Bhavikatti and Gayathri Bhavikatti.
Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office is at Lg – 2 Akshaya Complex Bailappanavar Nagar, Hubli, Karnataka, India – 580029.
As per the financials filed for FY 2015, the company reported a revenue of ₹7.24 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹4.53 Cr (net margin -62.6%) and EBITDA of -₹8.41 Cr (EBITDA margin -116.2%).
As per MCA filings, the company has open charges of ₹8.75 Cr on record. Court records list 8 cases involving the company, including 8 filed against it; 1 case is pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Imed Pharmaceuticals (India) Private Limited's registered office is in Hubli, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressLg – 2 Akshaya Complex Bailappanavar Nagar, Hubli, Karnataka, India – 580029
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Imed Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Imed Pharmaceuticals (India) Private Limited
FY 2015 filings availableImed Pharmaceuticals (India) Private Limited reported revenue of ₹7.24 Cr (down 30% YoY) for FY 2015.
Compounded Annual Growth Rate (CAGR)
Revenue fell 30% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | ₹7.24 Cr |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹8.41 Cr |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹4.53 Cr |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | -116.2% |
| Net Profit Margin | -62.6% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Imed Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Imed Pharmaceuticals (India) Private Limited
Imed Pharmaceuticals (India) has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narasappa Swamy Bhavikatti | Director | 15 Jul 2008 | 18 Years 3 Months | Current |
| Gayathri Bhavikatti | Director | 15 Jul 2008 | 18 Years 3 Months | Current |
Auditor
Imed Pharmaceuticals (India) Private Limited is audited by N S AYYANAGOUDAR & CO for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N S AYYANAGOUDAR & CO | FY 2015 | 000280S |
Shareholding
The shareholding of Imed Pharmaceuticals (India) Private Limited is on record for FY 2015, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2015 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Imed Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Dec 2012 | 10394589 | Axis Bank Limited | ₹3.75 Cr | Open | |
| 21 Aug 2012 | 10380225 | Krishnakumar G. Agrawal on Behalf of Kare Labs Private Limited | ₹5 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Imed Pharmaceuticals (India) Private Limited has 8 court cases on record: 8 filed against it. 1 case is pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Court case (Civ DJ) | Filed against the company by M/S Synokem Pharmaceuticals Ltd | Disposed |
| District court, DHARWAD, Karnataka | Criminal miscellaneous application | Filed against the company by The Deputy Commissioner of Commercial Taxes (Audit- and 1 other | Pending |
| District court, DHARWAD, Karnataka | Court case (R.A.) | Filed against the company by an individual | Disposed |
| District court, Panipat, Haryana | Civil suit | Filed against the company by M/S Elnova Pharma | Disposed |
| District court, East, Delhi | Criminal case | Filed against the company by an individual | Disposed |
To see the full case history of Imed Pharmaceuticals (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Imed Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Imed Pharmaceuticals (India) Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
GST
Imed Pharmaceuticals (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Imed Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Imed Pharmaceuticals (India) Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Deepak Arjundas Kukreja ceased to be Director on 31 Mar 2015.
Frequently asked questions
Imed Pharmaceuticals (India) is an active private limited company based in Hubli, Karnataka, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 15 July 2008 (18+ years old) and is registered under CIN U24200KA2008PTC047159.
Imed Pharmaceuticals (India) has 2 current directors:
- Narasappa Swamy Bhavikatti - Director
- Gayathri Bhavikatti - Director
The latest financial statements of Imed Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 September 2015. Year-wise statements from 2015 are in the company report.
No. Imed Pharmaceuticals (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Imed Pharmaceuticals (India) is U24200KA2008PTC047159. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imed Pharmaceuticals (India) has 8 court cases on record: 8 filed against it. 1 is pending.
Imed Pharmaceuticals (India) was incorporated on 15 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.
Deepak Arjundas Kukreja ceased to be Director on 31 Mar 2015. Sanjay Kukreja Cheturam ceased to be Director on 31 Mar 2015. Gayathri Bhavikatti was appointed as Director on 15 Jul 2008. Imed Pharmaceuticals (India) has 4 board changes on record in total.
The registered office of Imed Pharmaceuticals (India) is at Lg – 2 Akshaya Complex Bailappanavar Nagar, Hubli, Karnataka, India – 580029.
Imed Pharmaceuticals (India) operates in the healthcare industry, in the preventive health services segment.

